ClinicalTrials.govpublic full text
Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy
oral squamous cell carcinoma, toripalimab, neoadjuvant, pd-1 inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842875
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.